CSM Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.37M | Sell |
57,475
-780
| -1% | -$86.5K | 0.19% | 131 |
|
|
2025
Q1 | $6.53M | Sell |
58,255
-750
| -1% | -$84K | 0.36% | 66 |
|
|
2024
Q4 | $5.45M | Sell |
59,005
-4,760
| -7% | -$439K | 0.25% | 73 |
|
|
2024
Q3 | $5.35M | Sell |
63,765
-3,200
| -5% | -$268K | 0.35% | 77 |
|
|
2024
Q2 | $4.6M | Sell |
66,965
-1,310
| -2% | -$89.9K | 0.32% | 71 |
|
|
2024
Q1 | $5M | Sell |
68,275
-1,350
| -2% | -$98.9K | 0.33% | 76 |
|
|
2023
Q4 | $5.64M | Sell |
69,625
-995
| -1% | -$80.6K | 0.41% | 71 |
|
|
2023
Q3 | $5.29M | Sell |
70,620
-2,995
| -4% | -$224K | 0.46% | 65 |
|
|
2023
Q2 | $5.67M | Sell |
73,615
-1,150
| -2% | -$88.6K | 0.43% | 68 |
|
|
2023
Q1 | $6.2M | Hold |
74,765
| – | – | 0.54% | 54 |
|
|
2022
Q4 | $6.42M | Sell |
74,765
-1,960
| -3% | -$168K | 0.61% | 49 |
|
|
2022
Q3 | $4.73M | Sell |
76,725
-20,255
| -21% | -$1.25M | 0.52% | 59 |
|
|
2022
Q2 | $6M | Sell |
96,980
-10
| -0% | -$618 | 0.55% | 56 |
|
|
2022
Q1 | $5.77M | Sell |
96,990
-9,400
| -9% | -$559K | 0.39% | 67 |
|
|
2021
Q4 | $7.73M | Sell |
106,390
-3,520
| -3% | -$256K | 0.51% | 57 |
|
|
2021
Q3 | $7.68M | Hold |
109,910
| – | – | 0.57% | 51 |
|
|
2021
Q2 | $7.57M | Sell |
109,910
-5,280
| -5% | -$364K | 0.5% | 55 |
|
|
2021
Q1 | $7.45M | Buy |
+115,190
| New | +$7.45M | 1.05% | 40 |
|